DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Hodi FS, Ballinger M, Lyons B. et al.
Immune-modified response evaluation criteria in solid tumors (imRECIST): refining guidelines to assess the clinical benefit of cancer immunotherapy.
J Clin Oncol 2018;
36 (09) 850-858
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.